Position
Pfizer Inc in NextCure, Inc.
Back to the book · All holders of NXTC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$641K$14.19 → $10.01
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 157.6K | $2.24M | — | — | — | 0.9% |
| Q1 2026 | 153.4K | $1.54M | $10.01 | −$641K | −$60.9K | 0.6% |